MENU
OCUL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ocular Therapeutix (OCUL) Ownership - Who owns Ocular Therapeutix?
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
15 Crosby Drive
Phone
+1 781 357-4000
Employees
267
Web
https://www.ocutx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.26B
P/E Ratio
N/A
Total Cash
392.1M
Projected Growth
N/A
Total Debt
75.78M
Revenue
63.72M
Risk (Beta)
1.27
Dividend Yield
N/A
Total Cash/Share
2.47
Total Debt/Equity
N/A
Revenue/Share
0.40 USD as % of share price
Fundamentals
OCUL
Capitalization
1.26B
P/E Ratio
N/A
Risk (Beta)
1.27
Dividend Yield
N/A
Total Cash
392M
Total Cash/Share
2.47
Total Debt
75.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.40%
Revenue
63.7M
ROE
N/A
Book Value
315M
P/B Ratio
3.99
Cash Flow
N/A
Earnings
-1.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
16K
Current Ratio
10.66
Current Revenue Per Employee
62343.07
Dividends Per Share - Security
N/A
EBITDA
-176.14M
Float
N/A
Float - Current
N/A
Gross Income Margin
92.80
Revenue To Assets
-54.51
Shares Held By Institutions
1.38B
Shares Outstanding - Current
159M
Total Liabilities
143M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-8.080
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
15 Crosby Drive
Phone
+1 781 357-4000
Employees
267
Web
https://www.ocutx.com